|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus 显示文摘 | Vilsboll T Krarup J Sonne S | 2003 | J Clin Endocrinol Metab2003，88，： | 1 |
| 2 | Liraglutide, a longacting human glucagons-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes显示文摘 | Vilsboll T Zdravkovic M Le-Thi T | 2007 | Diabetes Care2007，30，6： | 1 |
| 3 | Incretins, insulin secretion and Type 2 diabetes mellitus 显示文摘 | 1 Vilsboll T Hoist JJ | 2004 | Diabetologia2004，47，： | 1 |
| 4 | Effects of glucagon-like peptidc-1 receptor agonists on weight loss :systematic review and meta - analyses of randomised controlled trials显示文摘 | VilsbOll T Christensen M Junker AE | 2012 | BMJ2012，344，： | 1 |
| 5 | Incretins, insulin secretion and typdiabetes显示文摘 | Vilsboll T Hoist J J | 2004 | Diabetologia2004，47，11： | 1 |
| 6 | The effects of glucagon-like peptide-1 on thebeta cell显示文摘 | Vilsboll T | 2009 | Diabetes Obes Metab2009，11，1： | 1 |
| 7 | Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus显示文摘 | Aaboe K Knop FK Vilsboll T | 2010 | Diabetes Obes Metab2010，12，4： | 1 |
| 8 | Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities显示文摘 | Lund A Knop FK Vilsboll T | 2014 | Eur J Intern Med2014，25，5： | 1 |
| 9 | Effects of glucagon-like peptide-I receptor agonists on weight loss: systematic review and meta- analyses of randomised controlled trials 显示文摘 | Vilsboll T Christensen M Junker AE | 2012 | BMJ2012，344，： | 1 |
| 10 | Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight显示文摘 | Schou JH Pilgaard K Vilsboll T | 2005 | J Clin Endocrinol Metab2005，90，8： | 1 |
| 11 | Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients显示文摘 | Vilsboll T Krarup T Deacon CF | 2001 | Diabetes2001，50，： | 1 |
| 12 | Evaluation of beta-cell secretory capacity using glucagon - like peptide 1 显示文摘 | Vilsboll T Toft-Nielsen MB Krarup T | 2000 | Diabetes Care2000，23，： | 1 |
| 13 | Defective amplification of the late phase insulin response to glu- cose by GIP in obese type II diabetic patients显示文摘 | Vilsboll T Krarup T Madsbad S | 2002 | Di- abetologia2002，45，8： | 1 |
| 14 | Is the current therapeutic armanmentarium in diabetes enough to control the epidemic and its consequences?What are the current shortcomings?显示文摘 | Giugliano D Standl E Vilsboll T | 2009 | Acta Diabetol2009，46，3： | 1 |
| 15 | Liraglutide , a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus 显示文摘 | Vilsboll T Brock B Perrild H | 2008 | Diabet Med2008，25，2： | 1 |
| 16 | The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action显示文摘 | Hare KJ Vilsboll T Asmar M | 2010 | Diabetes2010，59，7： | 1 |
| 17 | Reduced post- prandial concentration of intact biologically active glucagon like peptide- 1 in type 2 diabetic patients 显示文摘 | VILSBOLL T KRARUP T DEACON C F | 2001 | Diabetes2001，50，： | 1 |
| 18 | No reactive hypo-glycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose显示文摘 | Krarup T Madsbad S | 2001 | Diabet Med2001，18，2： | 1 |
| 19 | Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients显示文摘 | Vilsboll T Krarup T Madsbad S | 2002 | Diabetologia2002，45，： | 1 |
| 20 | Liraglutide,a longactinghuman glucagon -like peptide -1 analog, given asmonotherapy significantly improves glycemic control andlowers body weight without risk of hypoglycemia in patientswith type 2 diabetes显示文摘 | Vilsboll T Zdravkovic M Le-Thi T | 2007 | Diabets Care2007，30，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员